An estimation of the limitations to the use of life saving renin angiotensin aldosterone inhibitors in patients with acute MI and heart failure or left ventricular dysfunction. Data from the COSMOS s

被引:0
|
作者
Zannad, F. [1 ]
Leizorovicz, A. [2 ]
Quere, S. [3 ]
Fay, R. [1 ]
Grojean, S. [1 ]
Fiquet, B. [3 ]
Steg, P. H. -G. [4 ]
机构
[1] INSERM, CIC9501, Vandoeuvre Les Nancy, France
[2] Univ Lyon 1, F-69365 Lyon, France
[3] Novartis Pharmaceut, Rueil Malmaison, France
[4] Bichat Claude Bernard Hosp, AP HP, Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:742 / 742
页数:1
相关论文
共 50 条
  • [1] Use of Inhibitors of Renin-Angiotensin-Aldosterone System in Elderly Patients with Acute Decompensated Heart Failure and Depressed Left Ventricular Systolic Function
    Joo, Seung-Jae
    Choi, Joon-Hyuk
    Kim, Song-Yi
    Kim, Ki-Seok
    CIRCULATION, 2012, 126 (21)
  • [2] Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction
    Gradman, Alan H.
    Papademetriou, Vasilios
    AMERICAN HEART JOURNAL, 2009, 157 (06) : S17 - S23
  • [3] The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction
    Swedberg, K
    Sharpe, N
    EUROPEAN HEART JOURNAL, 1996, 17 (09) : 1306 - 1311
  • [4] Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy-from the KUNIUMI Registry Acute Cohort-
    Odajima, Susumu
    Tanaka, Hidekazu
    Fujimoto, Wataru
    Kuroda, Koji
    Yamashita, Soichiro
    Imanishi, Junichi
    Iwasaki, Masamichi
    Todoroki, Takashi
    Okuda, Masanori
    Hayashi, Takatoshi
    Konishi, Akihide
    Shinohara, Masakazu
    Toh, Ryuji
    Hirata, Ken-Ichi
    JOURNAL OF CARDIOLOGY, 2022, 79 (06) : 703 - 710
  • [5] Why are heart failure patients with left ventricular dysfunction not receiving angiotensin-converting enzyme inhibitors?
    Bart, BA
    Diem, SJ
    OConnor, CM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 96853 - 96853
  • [6] Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction
    Bart, BA
    Gattis, WA
    Diem, SJ
    OConnor, CM
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (08): : 1118 - +
  • [7] National patterns of use and effectiveness of angiotensin converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction
    Masoudi, FA
    Rathore, SS
    Wang, YF
    Havranek, EP
    Foody, JAM
    Krumholz, HM
    CIRCULATION, 2003, 108 (17) : 486 - 486
  • [8] Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis
    Xie, Wuxiang
    Zheng, Fanfan
    Song, Xiaoyu
    Zhong, Baoliang
    Yan, Li
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 205 : 65 - 71
  • [9] Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
    Beusekamp, Joost C.
    Tromp, Jasper
    van der Wal, Haye H.
    Anker, Stefan D.
    Cleland, John G.
    Dickstein, Kenneth
    Filippatos, Gerasimos
    van der Harst, Pim
    Hillege, Hans L.
    Lang, Chim C.
    Metra, Marco
    Ng, Leong L.
    Ponikowski, Piotr
    Samani, Nilesh J.
    van Veldhuisen, Dirk J.
    Zwinderman, Aeilko H.
    Rossignol, Patrick
    Zannad, Faiez
    Voors, Adriaan A.
    van der Meer, Peter
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (05) : 923 - 930
  • [10] National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction
    Masoudi, FA
    Rathore, SS
    Wang, YF
    Havranek, EP
    Curtis, JP
    Foody, JM
    Krumholz, HM
    CIRCULATION, 2004, 110 (06) : 724 - 731